Sun Pharma's FY20 Guidance Falls Short: Expert Insights from Research Delta Advisor 📉
Nimish Mehta, founder of Research Delta Advisor, discusses why Sun Pharma's FY20 outlook is disappointing and what it means for investors.
CNBC-TV18
2 views • May 29, 2019
About this video
Nimish Mehta, founder and director of Research Delta Advisor shared his take on Sun Pharmaceutical Industries' earnings.
Video Information
Views
2
Duration
7:18
Published
May 29, 2019
Related Trending Topics
LIVE TRENDSRelated trending topics. Click any trend to explore more videos.
Trending Now